Shah M, Marmarelis ME, Mamtani R, Hennessy S, et al. Association Between Survival and Very High Versus High PD-L1 Expression in Patients Receiving Pembrolizumab as First-line Treatment for Advanced Non-Small Cell Lung Cancer. Clin Lung Cancer 2022 Jul 22. pii: S1525-7304(22)00154.
PMID: 35945127